miR-129-1-3p 通过靶向 Runx2 调节环拉伸诱导的内皮祖细胞分化。
MicroRNA-129-1-3p regulates cyclic stretch-induced endothelial progenitor cell differentiation by targeting Runx2.
机构信息
Institute of Mechanobiology and Medical Engineering, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
出版信息
J Cell Biochem. 2019 Apr;120(4):5256-5267. doi: 10.1002/jcb.27800. Epub 2018 Oct 15.
Endothelial progenitor cells (EPCs) are vital to the recovery of endothelial function and maintenance of vascular homeostasis. EPCs mobilize to sites of vessel injury and differentiate into mature endothelial cells (ECs). Locally mobilized EPCs are exposed to cyclic stretch caused by blood flow, which is important for EPC differentiation. MicroRNAs (miRNAs) have emerged as key regulators of several cellular processes. However, the role of miRNAs in cyclic stretch-induced EPC differentiation remains unclear. Here, we investigate the effects of microRNA-129-1-3p (miR-129-1-3p) and its novel target Runt-related transcription factor 2 (Runx2) on EPC differentiation induced by cyclic stretch. Bone marrow-derived EPCs were exposed to cyclic stretch with a magnitude of 5% (which mimics physiological mechanical stress) at a constant frequency of 1.25 Hz for 24 hours. The results from a miRNA array revealed that cyclic stretch significantly decreased miR-129-1-3p expression. Furthermore, we found that downregulation of miR-129-1-3p during cyclic stretch-induced EPC differentiation toward ECs. Meanwhile, expression of Runx2, a putative target gene of miR-129-1-3p, was increased as a result of cyclic stretch. A 3'UTR reporter assay validated Runx2 as a direct target of miR-129-1-3p. Furthermore, small interfering RNA (siRNA)-mediated knockdown of Runx2 inhibited EPC differentiation into ECs and attenuated EPC tube formation via modulation of vascular endothelial growth factor (VEGF) secretion from EPCs in vitro. Our findings demonstrated that cyclic stretch suppresses miR-129-1-3p expression, which in turn activates Runx2 and VEGF to promote endothelial differentiation of EPCs and angiogenesis. Therefore, targeting miR-129-1-3p and Runx2 may be a potential therapeutic strategy for treating vessel injury.
内皮祖细胞 (EPCs) 对于恢复内皮功能和维持血管稳态至关重要。EPCs 动员到血管损伤部位并分化为成熟的内皮细胞 (ECs)。局部动员的 EPCs 暴露于血流引起的循环拉伸下,这对于 EPC 分化很重要。微小 RNA (miRNAs) 已成为几个细胞过程的关键调节因子。然而,miRNAs 在循环拉伸诱导的 EPC 分化中的作用尚不清楚。在这里,我们研究了微小 RNA-129-1-3p (miR-129-1-3p) 及其新型靶基因 Runt 相关转录因子 2 (Runx2) 对循环拉伸诱导的 EPC 分化的影响。将骨髓来源的 EPC 暴露于幅度为 5%(模拟生理机械应激)、频率为 1.25 Hz 的循环拉伸下 24 小时。miRNA 阵列的结果表明,循环拉伸显著降低了 miR-129-1-3p 的表达。此外,我们发现,在循环拉伸诱导的 EPC 向 EC 分化过程中,miR-129-1-3p 的下调。同时,作为 miR-129-1-3p 的假定靶基因,Runx2 的表达因循环拉伸而增加。3'UTR 报告基因实验验证了 Runx2 是 miR-129-1-3p 的直接靶基因。此外,小干扰 RNA (siRNA) 介导的 Runx2 敲低抑制了 EPC 向 EC 的分化,并通过调节 EPC 分泌血管内皮生长因子 (VEGF) 来减弱 EPC 管形成。我们的研究结果表明,循环拉伸抑制 miR-129-1-3p 的表达,从而激活 Runx2 和 VEGF,促进 EPC 的内皮分化和血管生成。因此,靶向 miR-129-1-3p 和 Runx2 可能是治疗血管损伤的潜在治疗策略。